Nasser H. Hanna

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy

Nasser H. Hanna, Frances A. Shepherd, Frank V. Fossella et al. · Journal of Clinical Oncology · 2004 · 2.4K citations · Full text

Medicine, Oncology, Pharmacology +15

Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer

Nasser H. Hanna, Paul A. Bunn, Corey J. Langer et al. · Journal of Clinical Oncology · 2006 · 678 citations · Full text

Medicine, Oncology, Pharmacology +10

Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Nasser H. Hanna, David H. Johnson, Sarah Temin et al. · Journal of Clinical Oncology · 2017 · 650 citations

Medicine, Oncology, Chemotherapy +12

Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology

Nasser H. Hanna, Marcus A. Neubauer, Constantin T. Yiannoutsos et al. · Journal of Clinical Oncology · 2008 · 496 citations

Medicine, Oncology, Radiation Oncology +15

Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Nasser H. Hanna, Bryan J. Schneider, Sarah Temin et al. · Journal of Clinical Oncology · 2020 · 455 citations

Medicine, Oncology, Pharmacotherapy +16